Vyome Holdings, Inc. (HIND) vs Psyence Biomedical Ltd. (PBM)

Vyome Holdings, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Vyome Holdings, Inc. and Psyence Biomedical Ltd. are of similar size ($11.4M and $11.2M). Vyome Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Psyence Biomedical Ltd. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Psyence Biomedical Ltd. leads on 7 and Vyome Holdings, Inc. on 3.

Valuation

Metric HIND PBM Biotechnology median
P/E n/m 0.13 10.60
P/S 86.52 n/m 9.40
P/B 1.54 0.06 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.91 0.66
EV/Sales 124.04 n/m 9.02
Earnings yield (223.64%) 742.35% (32.88%)
Free cash flow yield (49.67%) (1,121.21%) (23.13%)

Profitability

Metric HIND PBM Biotechnology median
Gross margin 52.77% — 68.51%
Operating margin (9,184.82%) — 0.00%
Net margin (8,711.71%) 0.00% 0.00%
Free cash flow margin (4,298.00%) 0.00% 0.00%
Return on equity (172.10%) (23.52%) (51.96%)
Return on assets (124.23%) (6.74%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HIND PBM Biotechnology median
Revenue growth (TTM) (67.10%) — 6.76%
EPS growth (last fiscal year) 99.92% (138.35%) 29.88%
Revenue growth, 5-year CAGR (50.98%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HIND PBM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.37 8.09 4.97
Net debt to EBITDA 0.48 1.20 1.01

Dividend

Metric HIND PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HIND PBM Biotechnology median
Market cap 11.44m 11.21m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack